Spain's national health service, INSALUD, has started to package certain drugs for use in its own hospitals as a way of curbing drug spending, reports the national daily El Pais. The scheme is at the experimental stage, and is being carried out at sites including the Santander hospital of Valdecilla.
The drugs being packaged for the service's exclusive use are clindamycin, ciprofloxacin, metronidazole, amoxicillin and vancomycin. Other reports add that zidovudine and ranitidine are also included. Raw materials are being sourced through laboratories in the Netherlands and Germany.
Spain's annual health budget is now about 3 billion pesetas ($21.6 million), with annual growth of 10% in the late 1980s. Health spending has come under close examination and all budgets have been trimmed, but drugs have suffered the most.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze